 Vijaya Vemulakonda
Concepts (243)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Urologic Surgical Procedures | 17 | 2025 | 113 | 4.080 |
Why?
| | Ureteral Obstruction | 7 | 2024 | 66 | 4.010 |
Why?
| | Hydronephrosis | 7 | 2024 | 37 | 2.790 |
Why?
| | Urology | 8 | 2024 | 62 | 2.310 |
Why?
| | Kidney Pelvis | 4 | 2024 | 24 | 1.800 |
Why?
| | Urinary Bladder | 6 | 2022 | 186 | 1.600 |
Why?
| | Renal Insufficiency | 3 | 2025 | 163 | 1.550 |
Why?
| | Electronic Health Records | 6 | 2022 | 1083 | 1.540 |
Why?
| | Vesico-Ureteral Reflux | 4 | 2024 | 33 | 1.460 |
Why?
| | Fetal Diseases | 2 | 2022 | 175 | 1.360 |
Why?
| | Kidney | 7 | 2025 | 1480 | 1.280 |
Why?
| | Infant | 27 | 2025 | 9565 | 1.120 |
Why?
| | Urinary Tract Infections | 5 | 2025 | 192 | 1.060 |
Why?
| | Urogenital Abnormalities | 4 | 2025 | 65 | 1.040 |
Why?
| | Pediatrics | 4 | 2019 | 1074 | 0.990 |
Why?
| | Urethral Diseases | 3 | 2022 | 20 | 0.950 |
Why?
| | Urinary Tract | 2 | 2024 | 49 | 0.940 |
Why?
| | Decision Making | 3 | 2024 | 944 | 0.860 |
Why?
| | Practice Patterns, Physicians' | 5 | 2025 | 1310 | 0.840 |
Why?
| | Child | 38 | 2025 | 21883 | 0.820 |
Why?
| | Ultrasonography, Doppler | 1 | 2024 | 123 | 0.820 |
Why?
| | Urologists | 2 | 2020 | 17 | 0.770 |
Why?
| | Urethral Obstruction | 1 | 2022 | 9 | 0.760 |
Why?
| | Amniotic Fluid | 1 | 2022 | 81 | 0.740 |
Why?
| | Urologic Diseases | 3 | 2018 | 39 | 0.700 |
Why?
| | Multicystic Dysplastic Kidney | 1 | 2020 | 3 | 0.690 |
Why?
| | Kidney Diseases, Cystic | 1 | 2020 | 25 | 0.680 |
Why?
| | Hypospadias | 2 | 2018 | 31 | 0.660 |
Why?
| | Child, Preschool | 23 | 2025 | 11130 | 0.660 |
Why?
| | Urinary Bladder, Neurogenic | 5 | 2022 | 39 | 0.660 |
Why?
| | Ultrasonography, Prenatal | 5 | 2022 | 286 | 0.660 |
Why?
| | Kidney Transplantation | 2 | 2022 | 703 | 0.660 |
Why?
| | Documentation | 1 | 2022 | 199 | 0.650 |
Why?
| | Biomedical Research | 2 | 2018 | 699 | 0.630 |
Why?
| | Humans | 62 | 2025 | 138651 | 0.620 |
Why?
| | Qualitative Research | 5 | 2022 | 1434 | 0.590 |
Why?
| | Stakeholder Participation | 1 | 2019 | 79 | 0.570 |
Why?
| | Fasting | 1 | 2020 | 282 | 0.570 |
Why?
| | Neurotoxicity Syndromes | 1 | 2018 | 35 | 0.570 |
Why?
| | Urinary Incontinence | 2 | 2016 | 66 | 0.570 |
Why?
| | Postnatal Care | 2 | 2015 | 71 | 0.560 |
Why?
| | Preoperative Care | 1 | 2020 | 364 | 0.550 |
Why?
| | Parents | 3 | 2023 | 1420 | 0.540 |
Why?
| | Urinary Fistula | 1 | 2017 | 9 | 0.540 |
Why?
| | Prenatal Diagnosis | 2 | 2020 | 190 | 0.520 |
Why?
| | Retrospective Studies | 24 | 2025 | 15860 | 0.520 |
Why?
| | Epispadias | 1 | 2016 | 4 | 0.510 |
Why?
| | Outpatients | 1 | 2020 | 412 | 0.510 |
Why?
| | Bladder Exstrophy | 1 | 2016 | 17 | 0.510 |
Why?
| | Urogenital Surgical Procedures | 1 | 2016 | 5 | 0.510 |
Why?
| | Female | 39 | 2025 | 73913 | 0.500 |
Why?
| | Urogenital System | 1 | 2016 | 17 | 0.500 |
Why?
| | Intermittent Urethral Catheterization | 1 | 2016 | 4 | 0.500 |
Why?
| | Clinical Decision-Making | 1 | 2019 | 332 | 0.490 |
Why?
| | Infant, Newborn | 12 | 2025 | 6143 | 0.490 |
Why?
| | Kidney Failure, Chronic | 1 | 2022 | 576 | 0.490 |
Why?
| | Risk Assessment | 5 | 2024 | 3459 | 0.470 |
Why?
| | Spinal Dysraphism | 2 | 2017 | 95 | 0.460 |
Why?
| | Appointments and Schedules | 2 | 2014 | 95 | 0.460 |
Why?
| | Anesthesia | 1 | 2018 | 226 | 0.460 |
Why?
| | Cultural Diversity | 2 | 2022 | 79 | 0.440 |
Why?
| | Urinary Bladder Neoplasms | 2 | 2008 | 256 | 0.440 |
Why?
| | Hernia, Umbilical | 1 | 2014 | 20 | 0.420 |
Why?
| | Anus, Imperforate | 1 | 2014 | 24 | 0.420 |
Why?
| | Urethra | 1 | 2014 | 53 | 0.410 |
Why?
| | Male | 35 | 2025 | 68216 | 0.400 |
Why?
| | Internship and Residency | 4 | 2024 | 1176 | 0.400 |
Why?
| | Wilms Tumor | 1 | 2013 | 87 | 0.380 |
Why?
| | Tumor Burden | 1 | 2013 | 307 | 0.380 |
Why?
| | Ambulatory Surgical Procedures | 1 | 2012 | 70 | 0.370 |
Why?
| | Patient Selection | 1 | 2015 | 692 | 0.360 |
Why?
| | Referral and Consultation | 1 | 2017 | 797 | 0.360 |
Why?
| | Botulinum Toxins, Type A | 3 | 2011 | 50 | 0.350 |
Why?
| | Physicians | 1 | 2020 | 927 | 0.350 |
Why?
| | Scoliosis | 1 | 2014 | 214 | 0.350 |
Why?
| | Data Collection | 1 | 2014 | 663 | 0.350 |
Why?
| | Ultrasonography | 4 | 2025 | 766 | 0.340 |
Why?
| | Adolescent | 17 | 2025 | 21528 | 0.320 |
Why?
| | Pregnancy | 5 | 2024 | 6836 | 0.320 |
Why?
| | Randomized Controlled Trials as Topic | 1 | 2015 | 1486 | 0.310 |
Why?
| | Tertiary Care Centers | 3 | 2019 | 170 | 0.300 |
Why?
| | Prospective Studies | 6 | 2025 | 7639 | 0.300 |
Why?
| | Dextrans | 1 | 2009 | 83 | 0.300 |
Why?
| | Postoperative Complications | 5 | 2024 | 2701 | 0.290 |
Why?
| | Cystitis | 2 | 2005 | 23 | 0.290 |
Why?
| | Prune Belly Syndrome | 1 | 2007 | 8 | 0.280 |
Why?
| | Ethics, Professional | 1 | 2007 | 14 | 0.270 |
Why?
| | Hyaluronic Acid | 1 | 2009 | 226 | 0.260 |
Why?
| | Follow-Up Studies | 6 | 2019 | 5160 | 0.260 |
Why?
| | Diurnal Enuresis | 1 | 2006 | 1 | 0.260 |
Why?
| | Competency-Based Education | 1 | 2007 | 70 | 0.250 |
Why?
| | Professional Competence | 1 | 2007 | 98 | 0.250 |
Why?
| | Stomach Neoplasms | 1 | 2008 | 118 | 0.250 |
Why?
| | Education, Medical, Graduate | 2 | 2024 | 490 | 0.250 |
Why?
| | Mullerian Ducts | 1 | 2025 | 13 | 0.230 |
Why?
| | Adenoma | 1 | 2007 | 225 | 0.230 |
Why?
| | Databases, Factual | 3 | 2022 | 1399 | 0.230 |
Why?
| | Biocompatible Materials | 1 | 2009 | 426 | 0.230 |
Why?
| | Incidence | 4 | 2024 | 2830 | 0.230 |
Why?
| | Negative-Pressure Wound Therapy | 1 | 2025 | 29 | 0.230 |
Why?
| | Feasibility Studies | 2 | 2022 | 970 | 0.220 |
Why?
| | Neuromuscular Agents | 1 | 2005 | 39 | 0.220 |
Why?
| | Renal Artery | 1 | 2024 | 40 | 0.210 |
Why?
| | Dissent and Disputes | 1 | 2023 | 20 | 0.210 |
Why?
| | Abnormalities, Multiple | 1 | 2025 | 195 | 0.200 |
Why?
| | Muscle, Smooth | 2 | 2022 | 152 | 0.200 |
Why?
| | Vascular Resistance | 1 | 2024 | 367 | 0.200 |
Why?
| | Urinary Bladder Diseases | 1 | 2022 | 18 | 0.190 |
Why?
| | Propensity Score | 1 | 2024 | 312 | 0.190 |
Why?
| | Drug Prescriptions | 1 | 2024 | 258 | 0.190 |
Why?
| | Patient Care | 1 | 2023 | 112 | 0.190 |
Why?
| | Duodenum | 1 | 2022 | 76 | 0.190 |
Why?
| | United States | 9 | 2025 | 15018 | 0.190 |
Why?
| | Laparoscopy | 2 | 2022 | 448 | 0.190 |
Why?
| | Reproducibility of Results | 2 | 2024 | 3311 | 0.190 |
Why?
| | Sexual Development | 1 | 2022 | 18 | 0.190 |
Why?
| | Ureter | 1 | 2022 | 34 | 0.180 |
Why?
| | Postoperative Period | 2 | 2020 | 355 | 0.180 |
Why?
| | Probability | 1 | 2022 | 309 | 0.180 |
Why?
| | Pain, Postoperative | 1 | 2024 | 298 | 0.180 |
Why?
| | Social Justice | 1 | 2022 | 79 | 0.180 |
Why?
| | Registries | 2 | 2022 | 2051 | 0.180 |
Why?
| | Urination | 3 | 2014 | 45 | 0.180 |
Why?
| | Surgical Wound Infection | 1 | 2025 | 308 | 0.180 |
Why?
| | Extracorporeal Membrane Oxygenation | 1 | 2025 | 319 | 0.180 |
Why?
| | Injury Severity Score | 1 | 2023 | 518 | 0.180 |
Why?
| | Bacteremia | 1 | 2024 | 214 | 0.180 |
Why?
| | Renal Replacement Therapy | 1 | 2022 | 89 | 0.180 |
Why?
| | Urography | 2 | 2014 | 19 | 0.180 |
Why?
| | Hospitals, Pediatric | 2 | 2025 | 516 | 0.180 |
Why?
| | Anti-Inflammatory Agents, Non-Steroidal | 1 | 2024 | 358 | 0.180 |
Why?
| | Neoplasm Recurrence, Local | 1 | 2007 | 1065 | 0.170 |
Why?
| | Trauma Centers | 1 | 2023 | 416 | 0.170 |
Why?
| | Adenocarcinoma | 1 | 2008 | 882 | 0.170 |
Why?
| | Ambulatory Care Facilities | 1 | 2022 | 246 | 0.170 |
Why?
| | Wounds, Nonpenetrating | 1 | 2023 | 289 | 0.170 |
Why?
| | Clinical Competence | 1 | 2008 | 1130 | 0.170 |
Why?
| | Actins | 1 | 2022 | 420 | 0.170 |
Why?
| | Treatment Outcome | 6 | 2025 | 10938 | 0.160 |
Why?
| | Anti-Bacterial Agents | 3 | 2025 | 1810 | 0.160 |
Why?
| | Cohort Studies | 4 | 2024 | 5729 | 0.160 |
Why?
| | General Surgery | 2 | 2024 | 174 | 0.150 |
Why?
| | Patient Portals | 1 | 2019 | 45 | 0.150 |
Why?
| | Ambulatory Care | 2 | 2022 | 574 | 0.150 |
Why?
| | User-Computer Interface | 1 | 2019 | 162 | 0.140 |
Why?
| | Bacteriuria | 1 | 2018 | 11 | 0.140 |
Why?
| | Urologic Surgical Procedures, Male | 1 | 2018 | 31 | 0.140 |
Why?
| | Renal Insufficiency, Chronic | 1 | 2024 | 621 | 0.140 |
Why?
| | Disorders of Sex Development | 1 | 2018 | 39 | 0.140 |
Why?
| | Renal Dialysis | 1 | 2022 | 439 | 0.140 |
Why?
| | Surveys and Questionnaires | 4 | 2024 | 5868 | 0.140 |
Why?
| | Curriculum | 1 | 2024 | 1005 | 0.140 |
Why?
| | Social Support | 1 | 2022 | 628 | 0.140 |
Why?
| | Cystostomy | 1 | 2017 | 8 | 0.140 |
Why?
| | Adult | 9 | 2025 | 38296 | 0.130 |
Why?
| | Mass Screening | 1 | 2025 | 1287 | 0.130 |
Why?
| | Acute Kidney Injury | 1 | 2024 | 811 | 0.130 |
Why?
| | Genital Diseases, Male | 1 | 2016 | 17 | 0.130 |
Why?
| | Analgesia | 1 | 2017 | 99 | 0.120 |
Why?
| | Analgesics, Opioid | 1 | 2024 | 1076 | 0.120 |
Why?
| | Fetus | 1 | 2020 | 801 | 0.120 |
Why?
| | Perioperative Care | 1 | 2018 | 196 | 0.120 |
Why?
| | Reoperation | 1 | 2018 | 585 | 0.120 |
Why?
| | Global Health | 1 | 2018 | 383 | 0.120 |
Why?
| | Length of Stay | 3 | 2025 | 1229 | 0.110 |
Why?
| | Risk Factors | 5 | 2018 | 10398 | 0.110 |
Why?
| | Caregivers | 1 | 2022 | 904 | 0.110 |
Why?
| | Health Information Exchange | 1 | 2014 | 23 | 0.100 |
Why?
| | Recovery of Function | 1 | 2018 | 666 | 0.100 |
Why?
| | ROC Curve | 1 | 2015 | 566 | 0.100 |
Why?
| | Cloaca | 1 | 2014 | 49 | 0.100 |
Why?
| | Age Factors | 3 | 2018 | 3274 | 0.100 |
Why?
| | Program Evaluation | 2 | 2008 | 911 | 0.100 |
Why?
| | Cystoscopy | 2 | 2011 | 23 | 0.090 |
Why?
| | Diagnostic Imaging | 1 | 2014 | 324 | 0.090 |
Why?
| | Urinary Retention | 1 | 2011 | 21 | 0.090 |
Why?
| | Sex Factors | 3 | 2018 | 2058 | 0.080 |
Why?
| | Severity of Illness Index | 2 | 2015 | 2861 | 0.080 |
Why?
| | Ureteroscopy | 1 | 2009 | 15 | 0.080 |
Why?
| | Patient Compliance | 1 | 2014 | 599 | 0.080 |
Why?
| | Injections | 1 | 2009 | 190 | 0.070 |
Why?
| | Electrocoagulation | 1 | 2007 | 39 | 0.070 |
Why?
| | Stomach | 1 | 2008 | 108 | 0.070 |
Why?
| | Anastomosis, Surgical | 1 | 2008 | 158 | 0.070 |
Why?
| | Young Adult | 4 | 2025 | 13322 | 0.060 |
Why?
| | Medical Staff, Hospital | 1 | 2007 | 81 | 0.060 |
Why?
| | Professional Role | 1 | 2007 | 167 | 0.060 |
Why?
| | Educational Measurement | 1 | 2008 | 292 | 0.060 |
Why?
| | Urothelium | 1 | 2005 | 38 | 0.060 |
Why?
| | Administration, Intravesical | 1 | 2005 | 16 | 0.060 |
Why?
| | Program Development | 1 | 2007 | 362 | 0.060 |
Why?
| | Congenital Abnormalities | 1 | 2025 | 93 | 0.050 |
Why?
| | Biopsy | 1 | 2007 | 1093 | 0.050 |
Why?
| | Faculty, Medical | 1 | 2007 | 290 | 0.050 |
Why?
| | Colorado | 1 | 2014 | 4528 | 0.050 |
Why?
| | Phimosis | 1 | 2003 | 1 | 0.050 |
Why?
| | Circumcision, Male | 1 | 2003 | 16 | 0.050 |
Why?
| | Tomography, X-Ray Computed | 1 | 2013 | 2703 | 0.050 |
Why?
| | Biomarkers | 1 | 2014 | 4111 | 0.050 |
Why?
| | Adenosine Triphosphate | 1 | 2005 | 489 | 0.050 |
Why?
| | Treatment Failure | 1 | 2024 | 350 | 0.050 |
Why?
| | Rats, Sprague-Dawley | 2 | 2005 | 2494 | 0.050 |
Why?
| | Disease Management | 1 | 2006 | 620 | 0.050 |
Why?
| | Career Choice | 1 | 2024 | 228 | 0.050 |
Why?
| | Abortion, Induced | 1 | 2024 | 102 | 0.050 |
Why?
| | Chronic Disease | 2 | 2005 | 1800 | 0.050 |
Why?
| | Magnetic Resonance Imaging | 1 | 2014 | 3642 | 0.040 |
Why?
| | Advisory Committees | 1 | 2022 | 219 | 0.040 |
Why?
| | Rats | 2 | 2005 | 5594 | 0.040 |
Why?
| | Pilot Projects | 1 | 2025 | 1757 | 0.040 |
Why?
| | Cryptorchidism | 1 | 2018 | 16 | 0.040 |
Why?
| | Urolithiasis | 1 | 2018 | 10 | 0.040 |
Why?
| | Intraoperative Period | 1 | 2018 | 67 | 0.040 |
Why?
| | Colony Count, Microbial | 1 | 2018 | 122 | 0.040 |
Why?
| | Urine | 1 | 2018 | 62 | 0.040 |
Why?
| | Stents | 1 | 2022 | 529 | 0.030 |
Why?
| | Constipation | 1 | 2018 | 98 | 0.030 |
Why?
| | Hospitalization | 1 | 2025 | 2219 | 0.030 |
Why?
| | Multivariate Analysis | 1 | 2018 | 1497 | 0.030 |
Why?
| | Emergency Service, Hospital | 1 | 2025 | 2103 | 0.030 |
Why?
| | Information Storage and Retrieval | 1 | 2014 | 118 | 0.020 |
Why?
| | Logistic Models | 1 | 2018 | 2088 | 0.020 |
Why?
| | Quality Improvement | 1 | 2020 | 1185 | 0.020 |
Why?
| | Injections, Intralesional | 1 | 2011 | 35 | 0.020 |
Why?
| | Urodynamics | 1 | 2011 | 46 | 0.020 |
Why?
| | Case-Control Studies | 1 | 2018 | 3581 | 0.020 |
Why?
| | Quality of Life | 1 | 2022 | 2954 | 0.020 |
Why?
| | Lower Urinary Tract Symptoms | 1 | 2011 | 61 | 0.020 |
Why?
| | Prognosis | 1 | 2018 | 4015 | 0.020 |
Why?
| | Behavior Therapy | 1 | 2011 | 268 | 0.020 |
Why?
| | Drug Therapy, Combination | 1 | 2011 | 1048 | 0.020 |
Why?
| | Combined Modality Therapy | 1 | 2011 | 1237 | 0.020 |
Why?
| | Physical Therapy Modalities | 1 | 2011 | 308 | 0.020 |
Why?
| | Time Factors | 1 | 2017 | 6877 | 0.020 |
Why?
| | Nerve Fibers, Unmyelinated | 1 | 2005 | 8 | 0.020 |
Why?
| | Animals | 2 | 2005 | 37309 | 0.010 |
Why?
| | Mechanoreceptors | 1 | 2005 | 17 | 0.010 |
Why?
| | Osmotic Pressure | 1 | 2005 | 35 | 0.010 |
Why?
| | Physical Stimulation | 1 | 2005 | 67 | 0.010 |
Why?
| | Cyclophosphamide | 1 | 2005 | 254 | 0.010 |
Why?
| | Sensory Receptor Cells | 1 | 2005 | 101 | 0.010 |
Why?
| | Muscle Contraction | 1 | 2005 | 435 | 0.010 |
Why?
| | Disease Models, Animal | 1 | 2005 | 4333 | 0.010 |
Why?
|
|
Vemulakonda's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|